Fresno Clinical Research Center

Freestone, California 93701

0 studies enrolling now · 1 studies all time

What they study most

Fibrosis, Liver Diseases, Non-alcoholic Steatohepatitis

Studies at this site

• Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis — Completed